[go: up one dir, main page]

NO884474L - Implanterbart, biologisk nedbrytbart virkestoff-frigjoeringssystem. - Google Patents

Implanterbart, biologisk nedbrytbart virkestoff-frigjoeringssystem.

Info

Publication number
NO884474L
NO884474L NO88884474A NO884474A NO884474L NO 884474 L NO884474 L NO 884474L NO 88884474 A NO88884474 A NO 88884474A NO 884474 A NO884474 A NO 884474A NO 884474 L NO884474 L NO 884474L
Authority
NO
Norway
Prior art keywords
implant
active substance
release system
substance release
biological degradable
Prior art date
Application number
NO88884474A
Other languages
English (en)
Other versions
NO176304B (no
NO884474D0 (no
NO176304C (no
Inventor
Herbert Stricker
Guenther Entenmann
Otto Kern
Michel Mikhail
Bernd Zierenberg
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO884474D0 publication Critical patent/NO884474D0/no
Publication of NO884474L publication Critical patent/NO884474L/no
Publication of NO176304B publication Critical patent/NO176304B/no
Publication of NO176304C publication Critical patent/NO176304C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO884474A 1987-10-09 1988-10-07 Fremgangsmåte for fremstilling av farmasöytiske implantater på basis av polylaktid NO176304C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873734223 DE3734223A1 (de) 1987-10-09 1987-10-09 Implantierbares, biologisch abbaubares wirkstofffreigabesystem

Publications (4)

Publication Number Publication Date
NO884474D0 NO884474D0 (no) 1988-10-07
NO884474L true NO884474L (no) 1989-04-10
NO176304B NO176304B (no) 1994-12-05
NO176304C NO176304C (no) 1995-03-22

Family

ID=6338006

Family Applications (1)

Application Number Title Priority Date Filing Date
NO884474A NO176304C (no) 1987-10-09 1988-10-07 Fremgangsmåte for fremstilling av farmasöytiske implantater på basis av polylaktid

Country Status (17)

Country Link
EP (1) EP0311065B1 (no)
JP (1) JP2763303B2 (no)
KR (1) KR970006082B1 (no)
AT (1) ATE101035T1 (no)
AU (1) AU609194B2 (no)
CA (1) CA1333770C (no)
DE (2) DE3734223A1 (no)
DK (1) DK175252B1 (no)
ES (1) ES2061589T3 (no)
FI (1) FI100302B (no)
IE (1) IE62505B1 (no)
IL (1) IL87973A (no)
NO (1) NO176304C (no)
NZ (1) NZ226514A (no)
PH (1) PH30236A (no)
PT (1) PT88703B (no)
ZA (1) ZA887535B (no)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US6323307B1 (en) 1988-08-08 2001-11-27 Cargill Dow Polymers, Llc Degradation control of environmentally degradable disposable materials
US5180765A (en) * 1988-08-08 1993-01-19 Biopak Technology, Ltd. Biodegradable packaging thermoplastics from lactides
US5216050A (en) * 1988-08-08 1993-06-01 Biopak Technology, Ltd. Blends of polyactic acid
US5444113A (en) * 1988-08-08 1995-08-22 Ecopol, Llc End use applications of biodegradable polymers
US5252642A (en) * 1989-03-01 1993-10-12 Biopak Technology, Ltd. Degradable impact modified polyactic acid
US5424346A (en) * 1988-08-08 1995-06-13 Ecopol, Llc Biodegradable replacement of crystal polystyrene
US5702716A (en) * 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
JPH05503286A (ja) * 1989-06-05 1993-06-03 マサチューセッツ インスティテュート オブ テクノロジー 骨における薬物送達のための生体侵食性ポリマー
US5487897A (en) 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
CH679207A5 (no) * 1989-07-28 1992-01-15 Debiopharm Sa
ES2052369T3 (es) * 1990-01-30 1994-07-01 Akzo Nv Articulo para el suministro controlado de una sustancia activa, que comprende un espacio hueco completamente cerrado por una pared y lleno en su totalidad o en parte con una o mas sustancias activas.
EP0447719B1 (en) * 1990-03-05 1993-11-03 Minnesota Mining And Manufacturing Company Device for extended delivery of pharmacologically active agents to the ear
US5350580A (en) * 1990-03-05 1994-09-27 Minnesota Mining And Manufacturing Company Device and method for extended delivery of pharmacologically active agents to the ear
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5681873A (en) * 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
US5605696A (en) * 1995-03-30 1997-02-25 Advanced Cardiovascular Systems, Inc. Drug loaded polymeric material and method of manufacture
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
BR9808456A (pt) * 1997-04-04 2000-05-23 Alcan Int Ltd Composição de liga de alumìnio e processo de fabricação
TW577759B (en) * 1997-04-18 2004-03-01 Ipsen Pharma Biotech Sustained release compositions in the form of microcapsules or implants and the process for their preparation
US6261583B1 (en) 1998-07-28 2001-07-17 Atrix Laboratories, Inc. Moldable solid delivery system
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
DE19908753C2 (de) * 1999-02-20 2003-10-02 Jenapharm Gmbh Bioabbaubare, injizierbare Oligomer-Polymer-Zusammensetzung
US6306425B1 (en) * 1999-04-09 2001-10-23 Southern Research Institute Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
US8226598B2 (en) 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US6702849B1 (en) 1999-12-13 2004-03-09 Advanced Cardiovascular Systems, Inc. Method of processing open-celled microcellular polymeric foams with controlled porosity for use as vascular grafts and stent covers
WO2001070846A1 (fr) 2000-03-22 2001-09-27 Dainippon Ink And Chemicals, Inc. Antichoc et composition polyester contenant ledit antichoc
EP1637126B1 (en) * 2000-07-05 2016-12-14 Allergan, Inc. Methods for treating inflammation of the eye
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
EP1339438B1 (en) 2000-11-29 2005-10-19 Allergan Inc. Preventing transplant rejection in the eye
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
CN100548271C (zh) 2004-01-20 2009-10-14 阿勒根公司 用于眼部的局部治疗、并优选包括有曲安奈德及透明质酸的组合物
US8425929B2 (en) 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US8512738B2 (en) 2004-04-30 2013-08-20 Allergan, Inc. Biodegradable intravitreal tyrosine kinase implants
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8673341B2 (en) 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US20050244458A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US8591885B2 (en) 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US20050244463A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
PT2010184E (pt) 2006-04-06 2013-04-03 Nupathe Inc Implantes para o tratamento dos estados associados à dopamina
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US8956641B2 (en) * 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of inflammatory diseases
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
ES2695931T3 (es) 2009-11-09 2019-01-11 Allergan Inc Composiciones y métodos para estimular el crecimiento del pelo
JP4779169B1 (ja) * 2010-10-27 2011-09-28 Ｎｅｃインフロンティア株式会社 ボタン照明構造、電子機器
CN109602691A (zh) 2013-02-15 2019-04-12 阿勒根公司 持续药物递送植入物
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
CN111432807A (zh) 2017-10-06 2020-07-17 铸造疗法股份有限公司 用于控制释放治疗剂的可植入贮库

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL109293C (no) * 1955-12-22
US3755558A (en) * 1971-02-23 1973-08-28 Du Pont Polylactide drug mixtures for topical application atelet aggregation
DE3218150C2 (de) * 1982-05-14 1986-09-25 Akzo Gmbh, 5600 Wuppertal Wirkstoff enthaltender Körper für die Langzeitabgabe sowie Verfahren zu dessen Herstellung
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
DE3710175A1 (de) * 1987-02-12 1988-08-25 Hoechst Ag Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung

Also Published As

Publication number Publication date
NZ226514A (en) 1990-02-26
FI884604A0 (fi) 1988-10-07
IE883040L (en) 1989-04-09
NO176304B (no) 1994-12-05
DK175252B1 (da) 2004-07-19
ES2061589T3 (es) 1994-12-16
KR970006082B1 (ko) 1997-04-23
AU609194B2 (en) 1991-04-26
PT88703A (pt) 1988-11-01
CA1333770C (en) 1995-01-03
DK561588D0 (da) 1988-10-07
EP0311065A1 (de) 1989-04-12
DE3887616D1 (de) 1994-03-17
ZA887535B (en) 1990-06-27
FI100302B (fi) 1997-11-14
FI884604L (fi) 1989-04-10
NO884474D0 (no) 1988-10-07
DK561588A (da) 1989-04-10
DE3734223A1 (de) 1989-04-20
IL87973A (en) 1992-08-18
IL87973A0 (en) 1989-03-31
KR890006222A (ko) 1989-06-12
PT88703B (pt) 1992-12-31
PH30236A (en) 1997-02-05
JP2763303B2 (ja) 1998-06-11
ATE101035T1 (de) 1994-02-15
EP0311065B1 (de) 1994-02-02
IE62505B1 (en) 1995-02-08
JPH02117A (ja) 1990-01-05
NO176304C (no) 1995-03-22
AU2352288A (en) 1989-04-13

Similar Documents

Publication Publication Date Title
NO884474L (no) Implanterbart, biologisk nedbrytbart virkestoff-frigjoeringssystem.
DE69434963D1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
FI872481A0 (fi) Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi
ATE222500T1 (de) Enythropoietin enthaltendes arzneimittelabgabesystem
NZ221484A (en) Starburst polymer conjugates as carriers for agricultural, pharmaceutical and other materials
DK0839525T3 (da) Præparat med forlænget frigivelse
NZ221390A (en) Biodegradable implant containing estradiol and poly(lactide-co-glycolide) polymer: method of administration and preparation
DE3780218D1 (de) Tumor-nekrose-faktor-formulierung und ihre herstellung.
DK305087A (da) Buprenorphinholdigt farmaceutisk suppositorium
DE3787477D1 (de) Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung.
DE3881615D1 (de) Wasserunloesliche cytokine.
DK330787A (da) Stabiliseret farmaceutisk sammensaetning
ATE85213T1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
DE3889933D1 (de) Perorale Arzneimittelzubereitung mit verzögerter Wirkstofffreigabe.
EP0380989A3 (en) Plaster for transdermal administration
DE69003466D1 (de) Substituierte Thienopyrimidin-Derivate, deren Herstellung, pharmazeutische Zusammensetzungen und medizinische Verwendung.
ATE175213T1 (de) Ch0ndromodulin-ii protein
FR2605223B1 (fr) Compositions therapeutiques stables a base d' huile vegetale hydrophobe et son procede de preparation

Legal Events

Date Code Title Description
MK1K Patent expired